DE69940352D1 - Verfahren zur herstellung von gamma delta t zellen - Google Patents

Verfahren zur herstellung von gamma delta t zellen

Info

Publication number
DE69940352D1
DE69940352D1 DE69940352T DE69940352T DE69940352D1 DE 69940352 D1 DE69940352 D1 DE 69940352D1 DE 69940352 T DE69940352 T DE 69940352T DE 69940352 T DE69940352 T DE 69940352T DE 69940352 D1 DE69940352 D1 DE 69940352D1
Authority
DE
Germany
Prior art keywords
cells
tcrgammadelta
interleukin
culturing
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940352T
Other languages
German (de)
English (en)
Inventor
David Nicholson Bell
Danna Lynn Skea
Phyllis Robin Hedge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapure Biopharma Inc
Original Assignee
Therapure Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapure Biopharma Inc filed Critical Therapure Biopharma Inc
Application granted granted Critical
Publication of DE69940352D1 publication Critical patent/DE69940352D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69940352T 1998-11-04 1999-11-04 Verfahren zur herstellung von gamma delta t zellen Expired - Lifetime DE69940352D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10700698P 1998-11-04 1998-11-04
PCT/CA1999/001024 WO2000026347A1 (en) 1998-11-04 1999-11-04 Methods for the production of tcr gamma delta t cells

Publications (1)

Publication Number Publication Date
DE69940352D1 true DE69940352D1 (de) 2009-03-12

Family

ID=22314363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940352T Expired - Lifetime DE69940352D1 (de) 1998-11-04 1999-11-04 Verfahren zur herstellung von gamma delta t zellen

Country Status (10)

Country Link
US (1) US6537812B1 (https=)
EP (1) EP1127107B1 (https=)
JP (1) JP4435985B2 (https=)
AT (1) ATE421573T1 (https=)
AU (1) AU759373B2 (https=)
CA (1) CA2349629C (https=)
DE (1) DE69940352D1 (https=)
ES (1) ES2319942T3 (https=)
NZ (1) NZ511760A (https=)
WO (1) WO2000026347A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449162T1 (de) * 2000-04-03 2009-12-15 Therapure Biopharma Inc Herstellung von tcr gamma delta t-zellen
US20030157060A1 (en) * 2000-04-03 2003-08-21 Bell David N Production of tcr gamma delta t cells
EP1778836B1 (en) * 2004-08-19 2010-08-04 University College Cardiff Consultants Limited Preparation of antigen-presenting human gamma delta t cells and use in immunotherapy
CN101313061B (zh) 2005-11-18 2013-05-15 大学健康网络 扩增双阴性t细胞的方法
CA2659697A1 (en) 2006-08-01 2008-02-07 Arigen Pharmaceuticals, Inc. Method of proliferating lak cell
GB201421716D0 (en) * 2014-12-05 2015-01-21 King S College London Cell expansion procedure
KR102663157B1 (ko) 2015-06-09 2024-05-13 감마델타 테라퓨틱스 엘티디 Ｔｃｒ감마 델타 양성 ｔ 세포의 생산 방법
AU2016274633B2 (en) * 2015-06-09 2022-04-21 Gammadelta Therapeutics Ltd Methods for the production of TCR gamma delta+ T cells
EP4148124A1 (en) 2015-10-30 2023-03-15 Cancer Research Technology Limited Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cells
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
KR20210111746A (ko) * 2018-11-08 2021-09-13 감마델타 테라퓨틱스 리미티드 세포를 단리 및 증식하는 방법
EP4198120A4 (en) * 2020-08-14 2024-05-08 Shanghai Xinghua Bio Pharmaceutical Science & Technology Co., Ltd METHOD FOR PREPARING UNIVERSAL IMMUNE CELLS AND THEIR USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639653A (en) * 1993-07-19 1997-06-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy Method for proliferating Vγ2Vδ2 T cells
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
CA2275141A1 (en) * 1996-10-29 1998-05-07 Thomas Spies Cell stress regulated human mhc class i gene
WO1998033891A1 (en) * 1997-01-31 1998-08-06 Hemosol Inc. Method for the production of selected lymphocytes
WO1999046365A1 (en) 1998-03-12 1999-09-16 Emory University Methods and compositions for the selective expansion of gamma/delta t-cells

Also Published As

Publication number Publication date
WO2000026347A1 (en) 2000-05-11
JP4435985B2 (ja) 2010-03-24
CA2349629A1 (en) 2000-05-11
AU1021900A (en) 2000-05-22
AU759373B2 (en) 2003-04-10
ES2319942T3 (es) 2009-05-14
EP1127107B1 (en) 2009-01-21
US6537812B1 (en) 2003-03-25
NZ511760A (en) 2003-10-31
ATE421573T1 (de) 2009-02-15
CA2349629C (en) 2010-01-26
JP2002528115A (ja) 2002-09-03
EP1127107A1 (en) 2001-08-29

Similar Documents

Publication Publication Date Title
DE60323468D1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
DE69940352D1 (de) Verfahren zur herstellung von gamma delta t zellen
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
DE69720026D1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
ATE153700T1 (de) Verfahren zur herstellung einer zeaxanthin enthaltenden zusammensetzung mittels eines mikroorganismus der spezies flavobacterium multivorum
WO2003089567A3 (en) Apparatus and method for a cell culture in a bioreactor at high cell concentration
EP1360314A4 (en) CHEMICALLY DEFINED MEDIUM FOR CULTIVATED MAMMALIAN CELLS
CA2058930A1 (en) Media for cell growth and method for making them
DE69617672D1 (de) Verfahren zur herstellung von 1,3-propandiol aus kohlenhydraten unter verwendung gemischter mikrobieller kulturen
DE69735059D1 (de) Erhöhte produktion von taxanen durch zellkulturen von taxus-arten
ATE82237T1 (de) Verfahren zur herstellung von tonerdekoerpern.
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
ES8403524A1 (es) Un procedimiento para obtener s-adenosil-metionina.
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE3582020D1 (de) Thermostabile alpha-amylase produzierende thermostabile anaerobe bakterie, thermostabile alpha-amylase und verfahren zur deren herstellung.
DE60118396D1 (de) Immobilisierungsträger mit einem porösen medium
DE3575743D1 (de) Verfahren zur gewinnung von phenylalanin-dehydrogenase enthaltenden mikroorganismen und deren verwendung zur herstellung von l-alpha-aminosaeuren.
DE68903570D1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
ATE31301T1 (de) Verfahren zur herstellung von 4-carbamoyl-1himidazolium-5-olat.
ATE51395T1 (de) Verfahren zur herstellung von rimantadin.
DE3486168D1 (de) Verfahren zur herstellung von l-glutaminsaeure durch fermentation und dabei zu verwendende mutante mikroorganismen.
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
DE3782333D1 (de) Verfahren und anlage zur herstellung von biogas aus dickfluessigen vergaerbaren medien.
DE50202362D1 (de) Verfahren zur Erhöhung der Wachstumsrate von Zellen in statischen Flüssigmedien
AT387972B (de) Verfahren zur herstellung phosphorsaeuregruppen enthaltender, waermehaertbarer (meth)-acrylcopolymer-bindemittel und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R079 Amendment of ipc main class

Ref document number: 1127107

Country of ref document: EP

Free format text: PREVIOUS MAIN CLASS: C12N0005060000

Ipc: C12N0005078300